Navigation Links
Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31
Date:7/24/2008

SOUTH SAN FRANCISCO, Calif., July 24 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that it will hold a conference call to discuss the Company's second quarter results and provide a corporate update, including an update on the clinical development plan for picoplatin, the Company's lead product candidate. Jerry McMahon, Ph.D., chairman and chief executive officer, Ronald A. Martell, president and chief operating officer, Caroline Loewy, chief financial officer, and Robert De Jager, M.D., FACP, chief medical officer, will host the call beginning at 5:00 p.m. Eastern time (2:00 p.m. Pacific time) on Thursday, July 31. A press release for the first quarter ended June 30, 2008, will be released after markets close on July 31.

To participate in the live call by telephone, please dial 877-419-6591 from the U.S. or +1-719-325-4901 for international callers. In addition, the live conference call is being webcast and can be accessed on the "Events" page of the "News & Events" section of the Company's website at http://www.poniard.com. A replay of the webcast will be available on the Company's website for 10 days.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead platform product candidate, is a new generation platinum therapy with an improved safety profile relative to existing platinum-based cancer therapies. Picoplatin is designed to overcome platinum resistance associated with chemotherapy in
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
2. Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market
3. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
5. Poniard Pharmaceuticals Announces Upcoming Conference Participation
6. Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
7. Poniard Pharmaceuticals Appoints Four New Members to Clinical Advisory Board
8. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
9. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
10. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
11. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , The researchers etched ... layer. Quantum dots are small structures that spontaneously emit light ... pulse is fired at the photonic crystal, its refractive index ... the electromagnetic field around it. This change can speed up ... As soon as the refractive index recovers its usual value, ...
(Date:9/30/2014)... AMHERST, Mass. Using a bio-mimicking analog of ... of grass, an international research team led by ... has taken a major step in developing long-sought ... to electricity for use in electronic devices. ... UMass Amherst and others at Stanford University and ...
(Date:9/30/2014)... September 30, 2014 Shimadzu Scientific ... an easy-to-use and highly precise tool for measuring ... considerable elongation. With 1000-mm maximum movement distance, the ... for a gauge length of 10 mm. In ... accuracy above 50-mm stroke and within +/- 100 ...
(Date:9/30/2014)... Proove Biosciences , the commercial and ... a new genetic test built upon research from their ... will provide physicians with an objective way to ... are stratified between individuals. With this new test, physicians ... a genetic predisposition that will affect their pain tolerance. ...
Breaking Biology Technology:Ultrafast remote switching of light emission 2Blades of grass inspire advance in organic solar cells 2Blades of grass inspire advance in organic solar cells 3Shimadzu’s New Long-Travel Extensometer Increases Precision for Soft Material Testing 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3
... and nothing happens. Shake this liquid, and free-floating sheets ... catalyze a reaction. This isn,t the latest gadget from ... the U. S. Department of Energy (DOE),s Lawrence Berkeley ... sheets of protein-like structures self-assemble. This "shaken, ...
... ALISO VIEJO, Calif., Oct. 27, 2011 Agilent Technologies ... today announced an agreement under which Ambry Genetics will ... sequencing services. (Logo:   http://photos.prnewswire.com/prnh/20110307/LA59848LOGO ) ... the highest quality results for exome sequencing for all ...
... N.J., Oct. 27, 2011 VetNostic Laboratories® offers ... owners. Using DNA analysis, they are able to ... dog carries disease-causing genes. Providing reliable identification of ... breeding program. At this time, VetNostic Laboratories® is ...
Cached Biology Technology:Shaken, not stirred: Berkeley lab scientists spy molecular maneuvers 2Agilent Technologies Signs Agreement to Supply Target Enrichment System to Ambry Genetics for Exome Sequencing 2VetNostic Laboratories® Announces New Testing for Dog Breeds 2VetNostic Laboratories® Announces New Testing for Dog Breeds 3
(Date:9/30/2014)... Prenatal exposure to tetrachloroethylene (PCE) in drinking water ... abruption, according to a new study led by ... , The study, published in the journal ... 1,019 unexposed pregnancies among 1,766 women in Cape ... late 1960s to the early 1980s by the ...
(Date:9/30/2014)... urban and farm runoff in Hawaii is causing tumors ... , The study, published Tuesday in the peer-reviewed open-access ... runoff ends up in algae that the turtles eat, ... flippers and internal organs. , Scientists at Duke University, ... Atmospheric Administration (NOAA) conducted the study to better understand ...
(Date:9/30/2014)... with IVF? Here,s some hope: A new research report ... FASEB Journal , explains how scientists developed a ... which induced embryo development in human and mouse eggs ... the sperm cell during fertilization. , "We believe that ... shift in our understanding of human fertilization by providing ...
Breaking Biology News(10 mins):Contaminated water linked to pregnancy complications, BU study finds 2Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3Synthetic sperm protein raises the chance for successful in vitro fertilization 2
... release is available in French . , Frank Kachanoff ... would make people more aggressive, not less. After all, dont football ... game in hopes of pumping them up? And what about our ... dares take their meat away from them? Wouldnt that go for ...
... as part of an insect birth control program helps ... new approach that combines the planting of pest-resistant cotton ... eliminated of the world,s most destructive cotton pests from ... Nov. 7 advance online publication of the journal ...
... tracking the flow of information in a cell preparing to ... coordinates and regulates the dynamics of shape change necessary for ... The protein, called 14-3-3, sits at an intersection where ... cell shape change and, ultimately, the splitting that allows for ...
Cached Biology News:Caveman behavioral traits might kick in at Thanksgiving table before eating 2New insect birth control strategy zaps cotton pests 2New insect birth control strategy zaps cotton pests 3New insect birth control strategy zaps cotton pests 4Johns Hopkins researchers reshape basic understanding of cell division 2
Dopamine D2 and D3 receptor, human and possibly mouse. AB1502 detects 40 ng of dopamine receptor peptide by ELISA. AB1502 is not neutralizing....
Anti-MMP-7, aminoterminal end active enzyme; rabbit host...
Request Info...
Rabbit polyclonal to Phosphothreonine-Proline / Phosphoserine-Proline ( Abpromise for all tested applications)....
Biology Products: